INTRODUCTION
Cell free hemoglobin (Hb) of oxygen carriers (CFH) has a very high affinity for NO which limits NO bioavailability, an effect that is hypothesized to promote systemic hypertension and microvascular vasoconstriction. Since CFHs are being developed to be used in critical conditions such as resuscitation from shock and the treatment of acute anemia, such a response would greatly limit their efficacy. Preventing vasoactivity and hypertension as a result of NO scavenging has been a major focus in the development and design of Hb-based blood replacement fluids. 1 The NO affinity of chemically modified Hbs (PEG-decorated and polymerized) is the same in vitro despite causing variable levels of hypertension in vivo. 2, 3 Hb extravasation into the vessel wall is presumed to cause NO scavenging. 4, 5 Polymerization of the protein which limits extravasation has in some cases elicited 6, 7 or prevented 8 hypertension. In general, large conjugated or polymerized Hbs with increased effective molecular radius appear to be inversely correlated with the hypertensive response. 9 Shielding of the Hb molecule by surface decoration or by encapsulation into vesicles increases the diffusion distance between Hb and the endothelium and may be another mechanism for reducing or eliminating the hypertensive response in vivo. [9] [10] [11] Presence of CFH in the plasma layer between RBCs and the endothelium should reduce perivascular NO levels as compared to RBCs alone and alter the diffusion field of NO towards the intravascular space lowering NO availability to smooth muscle causing varying degrees of systemic hypertension and microvascular vasoconstriction. In this study using the hamster window chamber, perivascular NO levels were measured after administration of CFH to determine the extent of changes in microvascular tone, perivascular NO concentration and mean arterial pressure after introducing different concentrations and types of modified CFH.
Direct comparison of these data will allow a better understanding if the change in NO levels by
CFH consistently leads to hypertension and vasoconstriction
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MATERIALS AND METHODS
Animal Preparation. Investigations were performed in 50 to 65 g male golden Syrian hamsters (Charles River Laboratories, Boston, MA). Animal handling and care were provided following the procedures outlined in the Guide for the Care and Use of Laboratory Animals (National Research Council, 1996) . The local Animal Subjects Committee approved this study. The hamster window chamber model is widely used for microvascular studies in the unanesthetized state, and the complete surgical technique for its the preparation has been previously described in detail. 12, 13 This model allows the study of an intact subcutaneous tissue and a single thin retractor muscle free from surgical manipulation and exposure to ambient atmospheric conditions.
Systemic and Laboratory Parameters. MAP and HR were monitored continuously (MP 150, Biopac System; Santa Barbara, CA) except when the catheters were used to take samples for laboratory parameters. An arterial blood sample, taken in a heparinized microcapillary tube (40 µl), was centrifuged to determine hematocrit (HCT). The plasma from this sample was used to determine plasma Hb concentration (B-Hemoglobin, HemoCue, Mission Viejo, CA).
Microhemodynamics. Arteriolar and venular blood flow velocities were measured on-line by using the photodiode cross-correlation method 14 (Photo Diode/Velocity Tracker 102B, Vista
Electronics, San Diego, CA). Measured centerline velocity (V) was corrected according to vessel size to obtain mean RBC velocity. 15 Video image-shearing was used to measure vessel diameter (D) (Image Shearing Monitor, Vista Electronics, San Diego, CA). 16 Blood flow (Q) was For personal use only. on October 31, 2017. by guest www.bloodjournal.org From each type), were characterized by their blood flow velocity and diameter. There was no selection bias since vessels were chosen from baseline observations and the same vessels were followed throughout the experiment.
NO Electrodes. Perivascular NO levels were measured using amperiometric bi-polymer coated (Nafion and o-phenylenediamine) carbon fiber microelectrodes. 17 Electrodes are fabricated by sequential dipping and drying in Nafion (5% in aliphatic alcohols, Sigma-Aldrich, St. Louis, MO).
Electrodes were additionally coated with 5mM o-phenylenediamine dihydrocholoride (1, 2-benzenediame solution) which selectively repels ascorbic acid and dopamine. 18 Current generated was measured with a potentiostat and an electrometer-amplifier (Keithley 610C, Cleveland, OH). Electrode selectivity to ascorbic acid was measured by its response to a 30 mM solution equilibrated with 100% Argon and compared to the magnitude of the response to 1 nM of NO. Only electrodes having less than a 2% response to ascorbic acid and an NO sensitivity of 7 nM were used in this study. Stability of the electrodes was reconfirmed after the measurements by repeating the calibration procedure. Electrodes outside the defined characteristics or had changed more than 5% caused both the data and electrode to be discarded from the study.
Perivascular NO Measurements. The window chamber cover glass was removed after completion of microhemodynamic measurements following treatment and the tissue was superfused (~5 ml/min) with physiological Krebs salt solution. The heated solution was equilibrated with 95% N 2 and 5% CO 2 , which maintained the suffusate at pH 7. The physical and oxygen transport properties of the solutions are summarized in Table   1 . 22 The metHb levels were measured spectrophotometrically (Lamda 20, Perkin-Elmer, Foster City, CA) to insure that they were < 5%. Experimental groups were: 1) 0.9% NaCl (Saline): Saline infusion was the no treatment group used to assess the effect of the experimental protocol. For personal use only. on October 31, 2017. by guest www.bloodjournal.org From kDa). The large molecular volume is due to the surface decoration by PEG; it has the largest effective molecular volume of the CFHs studied in this investigation. 4) Polymerized bovine Hb (PBH, Oxyglobin, Biopure Corp, Boston, MA): PBH is generated by oligomerization of bovine Hb using glutaraldehyde, which is then purified by size exclusion chromatography. It has an apparent molecular weight of 180kDa and accordingly should be a mixture of trimer and tetramers of bovine Hb. The molecular volume of PBH is intermediate to that of ααHb and MP4. PBH (13.0 g/dl) was diluted with 0.9% NaCl to obtain a 4% solution (PBH4).
The CFH samples were diluted to 4 g Hb/dl to match the concentration of MP4. The polymerized bovine Hb, PBH, was also used without dilution to study the concentration dependency of the response. 25 with the thermocouple implanted in the carotid artery and the indicator injected via a jugular catheter.
Cardiac Index (CI). Cardiac output (CO) was measured by a modified thermodilution technique
The probe and central catheter were placed surgically one day prior to measurements. On the day of the experiment, the femoral artery was catheterized to monitor blood pressure (FAP). Baseline measurements were made after recovery from anesthesia and when FAP was stable for 30 min (approximately 2 hr). CO and FAP were again assessed 30 min after treatment with CFHs. CI is CO divided by body weight. Peripheral vascular resistance (PVR) was estimated as FAP divided by CI.
Data Analysis. All values are shown as mean  ± standard deviation unless otherwise noted; n and N denote the number of animals and vessels studied respectively. Statistics were performed using Prism version 4.0 for Windows (GraphPad, San Diego, CA). Differences within groups were first tested with one way ANOVA for repeated measures and for multiple comparisons between groups. Bonferroni post hoc test was used if significance was obtained.
Changes were considered statistically significant if P<0.05.
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RESULTS

A. Microvascular Studies
All animals tolerated and completed the experimental protocols without any adverse events. A total of 37 animals were included in the microcirculation study and distributed into 7 experimental groups as follows: Control (n=6), LNAME (n=5), Saline (n=6), ααHb (n=5), MP4 (n=5), PBH4 (n=5) and PBH (n=5).
The systemic parameters for these animals (n=37) at baseline were: 1) MAP, 103 ± 9 mmHg; 2) HR, 417 ± 48 bpm; 3) HCT, 47.1 ± 2.1 %. Microvessels chosen for these studies were characterized by vessel diameter and blood flow at baseline. There were no statistical differences among the vessels chosen for the different experimental groups. The average vessel diameter and RBC velocity of the vessels studied for all experimental groups were for arterioles (N=200): 57.8 ± 17.5 µm and 4.7 ± 2.4 mm/sec, and venules (N=193): 68.6 ± 19.6 µm and 1.7 ± 0.9 mm/sec respectively. NO levels in the Control animals were 194 ± 88, and 189 ± 72 nM for arterioles and venules respectively. 
Scavenging of NO by CFH
The 5 experimental groups were treated with the hypervolemic infusion protocol: ∀∀Hb, MP4, PBH4 or PBH with Saline as the comparison group. All animals completed the protocol without adverse response. There were no statistically significant changes in HCT before and after administration of the CFH ( Table 2) . Comparison between the 4% CFH experimental groups found MP4 plasma Hb levels to be significantly lower relative to the ααHb (P=0.012) and PBH4 (P=0.057) experimental groups.
Infusion of Saline did not affect MAP and the slight decrease in HR was not statistically significant ( Figure 1B, circle) . Arteriolar and venular diameters and flows before and after CO was measured for all CFHs (n=4 per group). Baseline CI and FAP were 265 ± 59 ml/kg min and 99 ± 9 mmHg respectively ( Table 3) . Effect of Concentration: CI was statistically reduced relative to Saline for both concentrations. Changes in FAP for PBH4 and PBH were no different from Saline. However estimated PVR calculated using FAP was significantly increased for PBH relative to Saline. Effects of Molecular Configuration: CI was statistically lowered for ααHb and PBH4 relative to Saline and MP4 which were not different from each other. There were no changes in FAP among the CFH groups and Saline. The large reduction in CI for ααHb caused a significant increase in estimated PVR relative to the other groups.
DISCUSSION
The principal finding of this study is that the intravascular introduction of the three CFHs causes an increase in mean arterial pressure and a reduction in perivascular NO levels; however the reduction in perivascular NO levels did not result in proportional levels of microvascular vasoconstriction. Since these CFH are different in their molecular configurations, it follows that molecular structure of Hb plays a role in eliciting the vasoconstriction. Results summarized in Figure 3AB show that the reduction of perivascular NO is similar for all CFHs, therefore vascular responses are likely to involve other factors besides NO scavenging. The pressor effect of CFHs in vivo is well documented but there is only scattered information regarding concomitant effects on the microvascular tone and perivascular NO levels. This study also shows that systemic blood pressure and vascular tone in the tissue of the hamster window chamber model are not directly correlated.
NOS Inhibition. Blocking NO synthesis with LNAME treatment increased MAP, decreased HR and caused vasoconstriction. Perivascular NO levels did not fall to zero as predicted if all sources of NOS were completely blocked by LNAME. A possible interpretation of this finding is that the route of LNAME is diffusion limited and it may not reach the entire interstitial tissue and therefore not be able to block all sources of NO. Therefore the measurement of perivascular NO level represents a steady state flux of NO from interstitial sources. Additionally sources of nitrates may undergo reduction producing NO. In pilot studies, the LNAME dosage was presumably depleting all endothelial sources, thus increasing plasma Hb content did not further reduce perivascular NO levels. Therefore, only at very low plasma Hb concentrations it may be possible to detect a concentration dependent relationship between Hb and perivascular NO levels similar to those obtained in vitro. 27 Our finding does not preclude that some differences between CFHs and the scavenging rate of NO exists and suggests that in vivo this difference would be detectable at Hb concentrations that are too low for using these materials as physiological oxygen carriers. The difference in concentration was discernable in the increase in peripheral vascular resistance. In vivo studies in cats show that an increase in MAP after tetrameric Hb transfusion was blocked by prior LNAME treatment attributing the pressor response to NO scavenging. 6 Hb molecular configurations and oxygen transport characteristics. The molecular configurations of the three CFHs used in this study are different and should influence the rate at which these molecules extravasate the circulation, leading to the hypothesis that increasing molecular volume of these CFH would decrease their rate of exit from the circulation by kidney filtration and extravasation across the vascular wall. The presence of the Hb molecule in the vessel wall, as a consequence of extravasation, has been proposed to be an additional NO sink, limiting NO diffusion from endothelial cells to smooth muscle causing vasoconstriction. Studies have shown a strong correlation between molecular size, vasoconstriction and hypertension. 9 Infusion of CFHs with molecular diameters ranging from 7 to 68 nm showed that the constriction of resistance arterioles was proportional to the level of hypertension using the hamster window model. Recently studies with crosslinked tetrameric Hb (similar in size to ααHb used in the current study) found that CFH in the plasma does not scavenge sufficient NO in the plasma
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From space to significantly affect baseline tone in vascular beds with tight endothelial junctions found in the cranial circulation but does produce substantial constriction in beds with porous endothelium (kidney and small intestine) 6 supporting the hypothesis that vasoconstriction is due to extravasation of the CFH molecule. CFH has been shown to increase vascular permeability and induce vascular leaks in the intestine 28 further reducing NO availability to smooth muscle.
The hypothesis that low molecular weight components cause the pressor response was also explored with a dialyzed polymerized CFH (polymers > 300kDa, molecular radius estimated at 25 nm) and results suggest that exchange transfusion did not promote an increase in arterial pressure. 29 In the present investigation, the range of molecular radius studied is narrow therefore we cannot conclude that vasoconstriction found with ααHb and PBH4 was not in part due to extravasation.
Another possible mechanism to explain vasoconstriction is the rate of oxygen delivery to the vessel wall. 30, 31 The cardiovasculature delivers oxygen to tissue to match oxygen demand, and excessive delivery of oxygen or hyperoxia leads to autoregulatory arteriolar vasoconstriction to prevent tissue over oxygenation. CFH in plasma increases oxygen delivery due to facilitated diffusion which is directly proportional to the magnitude of the diffusion constant of the Hb molecule, which is inversely proportional to its molecular radius. The molecular radius of ααHb is about 3 nm, while that of MP4 is 9 nm, thus the flux of oxygen due to facilitated diffusion in the plasma layer in the presence of ααHb is 3 fold that of MP4. This effect is confirmed by studies using an artificial capillary system comparing CFHs with RBCs that showed that unmodified Hb and ααHb (small molecules) have markedly increased O 2 release relative to larger chemically modified Hb molecules regardless of their oxygen affinity (p50) 32 . Therefore the decreased diffusivity of MP4 in comparison to smaller CFH molecular configurations offsets the greater O 2 availability to the vessel wall due to facilitated diffusion.
This process is further enhanced by the higher oxygen affinity of MP4 which restricts oxygen release to locations with large oxygen gradients. Thus the combination of low diffusivity and increased oxygen affinity (lower p50) of MP4 reduces hyperoxia-driven vasoconstriction and as a result maintaining microvascular hemodynamics. It should be noted that hyperoxygenation of the microvascular wall is not necessarily related to an increase in pO 2 in this tissue. Facilitated diffusion increases oxygen delivery to the vascular wall while the driving pO 2 gradient is the same because CFH creates an additional oxygen flux due to the diffusion oxygen bound to molecular hemoglobin. Lowering NO availability in the microcirculation was shown to increase Table 2) . Furthermore, MP4 is the least likely molecule to extravasate due to its large molecular size as compared to the other CFH solutions. Thus the pressor response by MP4 may be attributed to an increase in blood volume which also leads to an increase in microvascular blood flow. There were no measurable differences between the systemic hematocrit in the MP4 group which may be due to the low resolution of the measurement technique.
Cardiac Index and Vascular Resistance MP4 has the same effect as Saline on the CI while PBH, PBH4 and ααHb lowered CI to 78%, 78% and 84% of baseline respectively. This finding further differentiates MP4 as a nonvasoactive material as shown by estimates of PVR calculated from femoral artery pressure (FAP) (see Table 3 , column 3). Unexpectedly the hypertension found using the MAP was not present in these experiments where the experimental procedure allowed measuring FAP but not MAP. These small animals have substantial pressure drops between the carotid and the femoral arteries due to the small caliber of the arterial vessels, as
shown by the consistent trend in the data despite its large dispersion. Using data on cardiac index and MAP measurements we again calculated PVR (Table 3, Volume expansion should increase in blood pressure for all materials except saline with the increased vascular resistance being an additional factor for PBH, PBH4 and ααHb. The differences in increased volume were not significant between materials. Increase in blood pressure is not necessarily pathological unless it is develops from an increased vascular resistance, in which case it decreases perfusion and FCD.
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The microvascular results in this study in the hamster window chamber model provide only a limited view of the microvascular response to CFHs. This model allows for detailed and precise location of the measurement of perivascular NO with concomitant determination of changes in vascular tone and blood flow. Lifting of the glass window and superfusion of the tissue to perform the NO measurements could change the microvascular environment. These effects were minimized by stabilizing the vascular tone and blood flow back to baseline levels prior to obtaining measurements. The baseline NO levels are in a similar range but are not as high as recently reported from measurements in the exteriorized rate mesentery and small intestine 35 which were in the 300 nM range. No differences in arteriolar and venular NO levels are similar to the finding by other studies. 35 36 However, It is unknown if similar responses are mirrored elsewhere particularly in major organs. It is likely that the limited field of view may in part explain why the increase in MAP with the lack of vasoconstriction is possible. Our previous studies with this experimental model and CFHs introduced in an extreme exchange transfusion protocol found the pressure drop in the microvascular network was located in different segments of the system.
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A greater pressure drop and corresponding vasoconstriction prior to the microcirculation was found for PBH and ααHb while for MP4 more of the systemic pressure was transmitted to the microcirculation. Maintenance of microvascular perfusion pressure by MP4
should be related to the lack of vasoconstriction observed in the present study. Some CFHs have been shown to decrease cardiac output in hemorrhagic shock resuscitation studies [38] [39] [40] [41] except for MP4, which recovered and sustained normal cardiac output. 42 Blood volume contracted and expanded in an moderate exchange transfusion study with ααHb and a bovine Hb modified with PEG respectively. 43 Mechanistically the behavior of PEG-Hb must be related to its unique ability of maintaining a significantly higher level of functional capillary density in extreme hemodilution and hemorrhagic shock resuscitation 44 , an effect not attainable with other CFHs. This result was obtained in experiments in the hamster window preparation and thus there is some uncertainty as to whether it is common to other organs and tissues. However, the increase in blood flow in the absence of vasodilation suggests that similar events may take place in the heart leading to increased perfusion pressure, improved capillary perfusion and cardiac function.
In summary the results of this study show perivascular NO scavenging is the same for all three molecular configurations of Hb when introduced into the circulation at the same concentration; however the microvascular effects of these solutions are different. This difference should be related to properties of the molecule other than NO binding. Among these properties might be their molecular volume, suggesting that extravasation and facilitated diffusion related mechanisms are factors that determine the effects on microvascular function.
Small molecules are vasoactive and raise blood pressure while MP4, with the largest molecular volume of all the CFHs studied here, does not cause vasoconstriction, but rather increased microvascular blood flow. MP4 also elicits a blood pressure rise; an effect that may be in part due to an increase in blood volume in combination with the maintenance of cardiac output, a consequence of its higher COP, as supported by the estimated blood volume expansion based on the changes in total Hb and no changes of peripheral vascular resistance. Conversely the remainder of CFHs increased blood pressure and significantly decreased cardiac output, due to a significant increase in vascular resistance. In summary, our findings support the concept that vasoconstriction does not directly correlate with NO scavenging by Hb-based oxygen carriers and provide evidence suggesting factors such as molecular dimension, retention time and gas carrying properties are more likely to regulate vascular tone and perfusion.
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[Hb], Hb concentration; [MetHb], metHb concentration; MW, Molecular weight; Molecular radius, indirectly determined from colloid osmotic pressure; Molecular volume, calculated from the molecular radius assuming a spherical shape; COP, colloid osmotic pressure measured at 25C viscosity (Colloid Osmometer, 4100, Wescor, Logan UT); Viscosity, 37C shear rate at 160 -1 (DV-II+, Brookfield, Middleboro, MA); p50, the partial pressure of oxygen at which the hemoglobin is 50% saturated. * NO binding rates measured by rapid mixing stopped-flow apparatus. ** From the product insert. Distribution of hemoglobin polymers with less than 5% of the hemoglobin as unstabilized tetramers, approximately 50% has a molecular weight between 65 and 130 kD, and no more than 10% has a molecular weight >500 kD. a , P = 0.022 among the 4g/dl CFH; 0.05 relative to other groups, pair wise comparison between 1) MP4 vs PBH4 (P = 0.057), 2) PBH4 vs.ααHb (P = 0.338) and 3) MP4 vs ααHb (P = 0.012). b, P < 0.05 relative to 4 g/dl CFHs 
